Benjamin A De Burgh

Title: The Innovations of Benjamin A De Burgh

Introduction

Benjamin A De Burgh is a notable inventor based in Winterbourne Down, GB. He is recognized for his significant contributions to the field of immunology, particularly in the development of human monoclonal antibodies. His work has implications for blood typing and the prevention of hemolytic disease in newborns.

Latest Patents

Benjamin A De Burgh holds a patent for "Human anti-RH(D) monoclonal antibodies, cell lines and methods of use." This invention provides human monoclonal antibodies with essential characteristics, including binding to the Rh(D) antigen while not interacting with other Rh blood group antigens. The antibodies are IgG3 proteins with kappa light chains and are of the allotype G3m(21). They are designed to bind to D.sup.u cells and various D variant antigens, making them useful for Rh-typing and passive immunization.

Career Highlights

He is currently associated with the National Blood Authority, where he continues to contribute to advancements in blood safety and immunology. His work has been pivotal in enhancing the understanding and treatment of Rh incompatibility in pregnancy.

Collaborations

Some of his notable coworkers include Alan Doyle and Belinda Mary Kumpel, who have collaborated with him on various projects related to blood research and antibody development.

Conclusion

Benjamin A De Burgh's innovative work in the field of monoclonal antibodies has made a significant impact on medical science, particularly in improving blood safety and health outcomes for newborns. His contributions continue to influence the field of immunology and patient care.